Coriolis is a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs and vaccines.

As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients.

We offer a large selection of services for all types of biopharmaceuticals, including proteins, peptides, peptides, nucleic acids, gene- and cell therapy products, vaccines and virus(-like) particles up to biosafety level S2.

Formulation research and development
    (from pre-formulation to market formulations)

Analytical method development
    (aggregate and particle characterization, protein analytics, GMP analytics)

Forced degradation and stability testing
    (stress conditions tailored for the product, stability testing according ICH)

Lyophilization
    (cycle development, scale up, modern PAT-tools)

Supply of pre-clinical material
    (GMP-like conditions in clean room)


Pharmaceutical

Biotechnology

Coriolis Pharma

Coriolis Pharma's headquarters in Martinsried (Munich), Germany

Description

People (43)

Silvia Steyrer-Gruber

Daniel Weinbuch

Stefan Lehnert

André São Pedro

Arindam Ghosh

Brecht Vanbillemont

Cinthya Tapia

Cornelia Zapp

Daniela Stadler

Daniel D.

Eva Kovač

Georg Schuster

Gokhan Kucukgoze

Gonzalo Rosso

Gulsum Meric

Hristina Andonoska

Janine Rauh

Julia Kralik

Juliane Bell

Kateřina Hinkelmann

Katharina Triebswetter

Kerstin Hausmann

Kristian le Vay

Lina Sophie Schlaeger

Lisa Besslich

Maitê Harguindeguy

Michaela Mitzkus

Dr. Nadine Werner

Owik Herold-Majumdar

Thomas L.

Maksymilian Zegota

Andrea Arsiccio

Gabriel Jones

Kavya Cukkemane

Dr. Mona Hoyos

Selma Gabbouj

Themistoklis Zisis

Wolfram Volkwein

Frank Schaubhut

Gerhard Sax

Katharina Kolland

Klingler Stefan

Ruedeeporn T.

Jobs